Given the liver’s central role in lipid metabolism, inflammation, and systemic homeostasis, SHMT2 dysfunction may also exacerbate extrahepatic complications, such as metabolic syndrome and cardiovascular comorbidities (Ghrayeb et al., 2024). Here, SHMT2 is linked to metabolic syndrome.